摘要
目的:分析孟鲁司特联合沙美特罗替卡松治疗支气管哮喘的临床效果。方法:收治支气管哮喘患者76例,平分两组。对照组给予单一沙美特罗替卡松治疗,观察组在此基础上加用孟鲁司特治疗,对两组治疗效果、肺功能指标改善情况等进行比较。结果:观察组治疗总有效率94.74%,与对照组的78.95%对比,差异有统计学意义(P<0.05)。两组肺功能指标改善情况,治疗后FEV1、FVC、PEF等指标对比,差异有统计学意义(P<0.05)。结论:支气管哮喘患者治疗中给予沙美特罗替卡松的同时,联合应用孟鲁司特,对帮助改善患者临床症状效果明显,且肺功能各项指标均可得到改善。
Objective:To analyze the clinical effect of montelukast combined with salmeterol and fluticasone in the treatment of bronchial asthma.Methods:76 cases of bronchial asthma were selected.Tthey were divided into the two groups on average.The control group was treated with salmeterol and fluticasone.The observation group was treated with montelukast on this basis.We observed and compared the treatment effect and the improvement of lung function index in the two groups of patients.Results:The effective rate of treatment in the observation group was 94.74%compared with the control group 78.95%,and the difference was statistically significant(P<0.05).The indexes of lung function improvement,and the differences of FEV1,FVC and PEF after treatment were statistically significant compared with those of the two groups(P<0.05).Conclusion:Montelukast combined with salmeterol and fluticasone in the treatment of bronchial asthma patients can improve the clinical symptoms of patients,and all indicators of lung function can be improved.
作者
郑朝军
Zheng Chaojun(The First People's Hospital of Fuquan City,Guizhou Province 550599)
出处
《中国社区医师》
2018年第10期29-30,共2页
Chinese Community Doctors
